Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costs.
about
Epidermal growth factor inhibitors in first-line for metastatic colorectal cancer with ras wild-type: a perspective based on pharmacological costs.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Epidermal growth factor inhibi ...... ased on pharmacological costs.
@en
type
label
Epidermal growth factor inhibi ...... ased on pharmacological costs.
@en
prefLabel
Epidermal growth factor inhibi ...... ased on pharmacological costs.
@en
P2860
P1476
Epidermal growth factor inhibi ...... ased on pharmacological costs.
@en
P2093
Andrea Bonetti
Jacopo Giuliani
P2860
P304
P356
10.1080/14737167.2017.1347504
P577
2017-06-24T00:00:00Z